DS-1123

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameDS-1123

Drug Alias NameDS-1123DS-1123a

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionFibroblast growth factor receptor 2 antagonists

TargetsFibroblast growth factor receptor 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A